Glioblastoma (GBM) is the most common primary malignant brain tumor in adults.
Regardless of ideal multidisciplinary treatment, including maximal surgical resection …

Despite aggressive management consisting of maximal safe surgical resection followed by
external beam radiation therapy (60 Gy/30 fractions) with concomitant and adjuvant …

Background Boron neutron capture therapy (BNCT) utilizes tumor-selective particle
radiation. This study aimed to assess the safety and efficacy of accelerator-based BNCT (AB …

Glioblastoma (GBM) is the most aggressive, deadliest, and most common brain malignancy
in adults. Despite the advances made in surgical techniques, radiotherapy and …

Importance Glioblastoma is the most common primary malignant brain tumor, but despite
multimodal treatment with surgery, radiotherapy, and temozolomide chemotherapy, the …

Background Amide proton transfer (APT) MRI has the potential to demonstrate antitumor
effects by reflecting biologically active tumor portion, providing different information from …

Glioblastoma, the most common primary malignant brain tumor in adults, is highly
aggressive and associated with a poor prognosis. Bevacizumab, a monoclonal antibody …

The primary aim of this review is to provide practical recommendations in terms of
fractionation, dose, constraints and selection criteria to be used in the daily clinical routine …

Recent studies suggested that postoperative hypoxia might trigger invasive tumor growth,
resulting in diffuse/multifocal recurrence patterns. Aim of this study was to analyze distinct …

Re-irradiation has been shown to be a meaningful option for recurrent high-grade glioma
(HGG) patients. Furthermore, bevacizumab exerts certain activity in combination with …